The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance. (Q38100050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Yvonne Tam

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

6

Sue J Goldie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

10

Peter M Strebel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

15

Neff Walker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Lisa A Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Lauren Franzel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Deblina Datta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Ingrid K Friberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Susan E Reef

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Nina Schwalbe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Emily Simons

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Steven Sweet

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Chutima Suraratdecha

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Emilia Vynnycky

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Damian G Walker

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Peter M Hansen

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

1 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

31 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

B61-72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23598494%20AND%20SRC:MED&resulttype=core&format=json

Global Vaccine Action Plan. Decade of vaccine collaboration

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Methods used in the Lives Saved Tool (LiST).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Global, regional, and national causes of child mortality in 2008: a systematic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Predicting the distribution of under-five deaths by cause in countries without adequate vital registration systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Estimating child mortality due to diarrhoea in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Rotavirus and severe childhood diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Effect of rotavirus vaccination on death from childhood diarrhea in Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Multiparameter Calibration of a Natural History Model of Cervical Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Cost-effectiveness of HPV 16, 18 vaccination in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Cost-effectiveness of cervical-cancer screening in five developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Mathematical models of cervical cancer prevention in Latin America and the Caribbean

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Mathematical models of cervical cancer prevention in the Asia Pacific region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Estimated global incidence of Japanese encephalitis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

7 January 2021

Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Modelling the incidence of congenital rubella syndrome in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Consequences of confirmed maternal rubella at successive stages of pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Costs of congenital rubella syndrome (CRS) in Oman: evidence based on long-term follow-up of 43 children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Unseen blindness, unheard deafness, and unrecorded death and disability: congenital rubella in Kumasi, Ghana

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

inferred from DOI database lookup

7 January 2021

based on heuristic

Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

The Global Burden of Measles in the Year 2000—A Model that Uses Country‐Specific Indicators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Field effectiveness of live attenuated measles-containing vaccines: a review of published literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Estimates of measles case fatality ratios: a comprehensive review of community-based studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Persistent Efficacy of Vi Conjugate Vaccine against Typhoid Fever in Young Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Real-world impact of rotavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Assessing vaccine efficacy in the field. Further observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Acute lower respiratory infection in the developing world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Monitoring global health: time for new solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Estimates of world-wide distribution of child deaths from acute respiratory infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Results from nationwide hepatitis B serosurvey in Cambodia using simple and rapid laboratory test: implications for National Immunization Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Impact of Haemophilus influenzae type b conjugate vaccine on bacterial meningitis in the Dominican Republic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035

Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.035